Rivastigmine 13.3mg/24h transdermal patch (Voleze®)
Shared care guideline available
- Traffic LightAmber (SCG)
- BNF
- Licensed IndicatorsMild to moderate severe alzhemiers disease
- ReferenceAPC Jan 15
- Criteria
- ProvisionalNo
Do you want to add this to your CPD record?
Did you find this page helpful?